Etanercept-induced dermatitis in a patient with rheumatoid arthritis [8]

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 5, 2006, Pages 614-615

  Lai Cheong, Jelai ^a   Warren, R ^a   Bucknall, R ^a   Parslew, R ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMLODIPINE; ATENOLOL; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; LANSOPRAZOLE; LEFLUNOMIDE; SKIN PROTECTIVE AGENT; STEROID;

ACANTHOSIS; AGED; CASE REPORT; DRUG ERUPTION; EXOCYTOSIS; FEMALE; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HYPERKERATOSIS; HYPERTENSION; LETTER; NUMMULAR DERMATITIS; OSTEOPOROSIS; PARAKERATOSIS; PRIORITY JOURNAL; PRURITUS; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN DEFECT; SKIN INFLAMMATION; TOXIC EPIDERMAL NECROLYSIS; TREATMENT FAILURE;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG ERUPTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 33646043438     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01497.x     Document Type: Letter

References (6)

1. Mease PJ, Goffe BS, Metz J et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomised trial. Lancet 2000; 356: 385-390.
2. Moreland L, Cohen S, Fleischmann RM et al. Safety and efficacy of up to five years etanercept (Enbrel) therapy in rheumatoid arthritis. Poster presented at EULAR 2002, Stockholm, Sweden, 2002.
3. Weinblatt ME, Kremer JM, Bankhurst AD et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999; 340: 253-259.
4. Shakoor N, Michalska M, Harris CA et al. Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 2002; 359: 579-580.
5. Soliotis F, Glover M, Jawad ASM. Severe skin reation after leflunomide and etanercept in a patient with rheumatoid arthritis. Ann Rheum Dis 2002; 61: 850-852.
6. Chan JL, Davis-Reed L, Kimball AB. Counter-regulatory balance: Atopic dermatitis in patients undergoing infliximab infusion therapy. J Drugs Dermatol 2004; 3: 315-318.